CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | tunicamycin C1 |
|
Accession: | CHEBI:64256
|
browse the term
|
Definition: | A nucleoside that is one of the homologues in the mixture that is tunicamycin, characterised by a 14-methylpentadec-2-enoyl fatty acyl substituent on the amino group of the tunicamine moiety. |
Synonyms: | exact_synonym: | (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-hydroxyethyl}-4,5-dihydroxytetrahydro-2H-pyran-3-yl]-14-methylpentadec-2-enamide; (5'R)-5'-[2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<->1)-2,6-dideoxy-2-(14-methylpentadec-2-enamido)-beta-D-galactopyranos-6-yl]uridine |
| related_synonym: | Formula=C39H64N4O16; InChI=1S/C39H64N4O16/c1-20(2)14-12-10-8-6-4-5-7-9-11-13-15-25(47)41-28-32(52)29(49)23(56-38(28)59-37-27(40-21(3)45)31(51)30(50)24(19-44)57-37)18-22(46)35-33(53)34(54)36(58-35)43-17-16-26(48)42-39(43)55/h13,15-17,20,22-24,27-38,44,46,49-54H,4-12,14,18-19H2,1-3H3,(H,40,45)(H,41,47)(H,42,48,55)/b15-13+/t22-,23-,24-,27-,28-,29+,30-,31-,32-,33+,34-,35-,36-,37-,38+/m1/s1; InChIKey=ZOCXUHJGZXXIGQ-NPXWYGMKSA-N; SMILES=[H][C@@](O)(C[C@H]1O[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@H](NC(=O)\\C=C\\CCCCCCCCCCC(C)C)[C@@H](O)[C@H]1O)[C@@]1([H])O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O; corynetoxin U-16I; tunicamycin B; tunicamycin VII |
| xref: | CAS:66081-36-5; Chemspider:27471426; MetaCyc:CPD-19373; PMID:29844049; PMID:29973921; PMID:30445836; PMID:33636028; PMID:7061468 |
|
|
|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AARS1 mRNA; Tunicamycin results in increased expression of AARS1 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Aarsd1 |
alanyl-tRNA synthetase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AARSD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:86,340,625...86,353,729
Ensembl chr10:86,340,626...86,353,729
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of ABCB1 mRNA Tunicamycin results in decreased expression of ABCB1 protein 1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea inhibits the reaction [Tunicamycin results in decreased expression of ABCB1 protein] |
CTD |
PMID:29453283 PMID:34915026 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCB1B mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCB7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCC1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ABCC3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abce1 |
ATP binding cassette subfamily E member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABCE1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
|
|
G |
Abitram |
actin binding transcription modulator |
increases expression |
ISO |
Tunicamycin results in increased expression of ABITRAM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:71,505,853...71,524,224
Ensembl chr 5:71,505,813...71,511,890
|
|
G |
Abtb1 |
ankyrin repeat and BTB domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ABTB1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of ACACA mRNA Tunicamycin results in decreased expression of ACACA mRNA |
CTD |
PMID:22378314 PMID:22414386 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACACB mRNA |
CTD |
PMID:17127020 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acad10 |
acyl-CoA dehydrogenase family, member 10 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACAD10 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACAD11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAD9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
increases expression |
ISO |
Tunicamycin results in increased expression of ACADVL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAT1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACAT2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acbd3 |
acyl-CoA binding domain containing 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACBD3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:92,455,813...92,484,556
Ensembl chr13:92,455,655...92,483,380
|
|
G |
Acer3 |
alkaline ceramidase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACER3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACLY mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acot13 |
acyl-CoA thioesterase 13 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOT13 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
|
|
G |
Acot7 |
acyl-CoA thioesterase 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOT7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACOX1 mRNA |
CTD |
PMID:22414386 |
|
NCBI chr10:101,406,197...101,431,242
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acp6 |
acid phosphatase 6, lysophosphatidic |
increases expression |
ISO |
Tunicamycin results in increased expression of ACP6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACSL5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
Tunicamycin results in increased expression of ACTA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACTB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ACTG1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
|
|
G |
Acvr1 |
activin A receptor type 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACVR1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
Tunicamycin results in increased expression of ACVR1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ACY1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam23 |
ADAM metallopeptidase domain 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAM23 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:64,862,878...65,006,515
Ensembl chr 9:64,862,878...65,006,515
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAMTS1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADAMTS9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
Tunicamycin results in increased expression of ADIPOQ mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Tunicamycin results in increased expression of ADM mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ADM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:120,393,219...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADORA2B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adprm |
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent |
increases expression |
ISO |
Tunicamycin results in increased expression of ADPRM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:51,732,073...51,744,635
Ensembl chr10:51,731,993...51,744,635
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ADRM1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of AEN mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Aga |
aspartylglucosaminidase |
increases expression |
ISO |
Tunicamycin results in increased expression of AGA mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:38,504,661...38,516,607
Ensembl chr16:38,504,663...38,516,606
|
|
G |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AGAP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:90,039,760...90,475,196
Ensembl chr 9:90,039,605...90,470,958
|
|
G |
Agk |
acylglycerol kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AGK mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934
|
|
G |
Agtpbp1 |
ATP/GTP binding carboxypeptidase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AGTPBP1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
|
|
G |
Ahcyl2 |
adenosylhomocysteinase-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AHCYL2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AHI1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:15,768,047...15,886,744
Ensembl chr 1:15,762,462...15,891,041
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
ISO |
Tunicamycin results in increased expression of AHNAK mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AHSA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Ak2 |
adenylate kinase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AK4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Ak5 |
adenylate kinase 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of AK5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
|
|
G |
Akap17a |
A-kinase anchoring protein 17A |
increases expression |
ISO |
Tunicamycin results in increased expression of AKAP17A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
increases expression |
ISO |
Tunicamycin results in increased expression of AKAP8 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akna |
AT-hook transcription factor |
increases expression |
ISO |
Tunicamycin results in increased expression of AKNA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AKR1C21 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO EXP |
Tunicamycin results in decreased phosphorylation of AKT1 protein [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein] MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:22378314 PMID:24680926 PMID:24898257 PMID:25398788 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH1A2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:20,254,196...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ALDH6A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ALDH7A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of ALDOC mRNA Tunicamycin results in increased expression of ALDOC mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALG5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:138,936,998...138,951,228
Ensembl chr 2:138,936,993...138,951,216
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALG9 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
|
|
G |
Alkbh3 |
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase |
increases expression |
ISO |
Tunicamycin results in increased expression of ALKBH3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:79,939,515...79,972,820
Ensembl chr 3:79,939,600...79,972,000
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions increases degradation |
ISO EXP |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tretinoin inhibits the reaction [Tunicamycin results in increased degradation of ALPL protein]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] |
CTD |
PMID:10567916 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amot |
angiomotin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AMOT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr X:108,982,399...109,041,265
Ensembl chr X:108,984,022...109,041,272
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of AMT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Anapc11 |
anaphase promoting complex subunit 11 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:105,875,209...105,886,307
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:156,238,640...156,266,005
Ensembl chr 1:156,262,841...156,268,145
|
|
G |
Anapc16 |
anaphase promoting complex subunit 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANAPC16 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:27,927,334...27,941,681
Ensembl chr20:27,927,334...27,941,984
|
|
G |
Anapc7 |
anaphase promoting complex subunit 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANAPC7 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:34,131,214...34,160,819
Ensembl chr12:34,133,429...34,160,005
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANK2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANKRD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANKRD12 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
|
|
G |
Ankrd39 |
ankyrin repeat domain 39 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANKRD39 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:38,780,291...38,790,177
Ensembl chr 9:38,781,785...38,790,201
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa4 |
annexin A4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ANXA4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Anxa6 |
annexin A6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ANXA6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AP1B1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap3d1 |
adaptor related protein complex 3 subunit delta 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3D1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3M2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP3S2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:133,818,825...133,859,269
Ensembl chr 1:133,818,825...133,859,322
|
|
G |
Ap5s1 |
adaptor related protein complex 5 subunit sigma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of AP5S1 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 3:118,429,618...118,436,256
Ensembl chr 3:118,429,637...118,432,926
|
|
G |
Apcs |
amyloid P component, serum |
increases expression |
ISO |
Tunicamycin results in increased expression of APCS mRNA |
CTD |
PMID:22414386 |
|
NCBI chr13:85,373,338...85,374,134
Ensembl chr13:85,373,220...85,374,298
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APEX2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
|
|
G |
Apob |
apolipoprotein B |
decreases secretion multiple interactions |
ISO |
Tunicamycin results in decreased secretion of APOB protein [ursodoxicoltaurine co-treated with Tunicamycin] results in increased expression of APOB mRNA; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased secretion of APOB protein] |
CTD |
PMID:32535746 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoc2 |
apolipoprotein C2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APOC2 mRNA |
CTD |
PMID:17127020 PMID:22414386 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of APOC3 mRNA |
CTD |
PMID:32535746 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions increases secretion |
ISO |
[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form]; Quercetin inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] |
CTD |
PMID:22115781 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arcn1 |
archain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARCN1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:45,057,617...45,082,224
Ensembl chr 8:45,057,619...45,082,247
|
|
G |
Arf4 |
ADP-ribosylation factor 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARF4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
|
|
G |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARFGAP3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARG2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap45 |
Rho GTPase activating protein 45 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARHGAP45 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARHGEF2 mRNA; Tunicamycin results in increased expression of ARHGEF2 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arid3b |
AT-rich interaction domain 3B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARID3B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARID5B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Arih2 |
ariadne RBR E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARIH2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
|
|
G |
Arl1 |
ADP-ribosylation factor like GTPase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARMCX1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARMCX3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ARRB1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of ARRDC4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
|
|
G |
Asb3 |
ankyrin repeat and SOCS box-containing 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASB3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:104,659,406...104,788,032
Ensembl chr14:104,611,010...104,788,028
|
|
G |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASCC2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:79,503,449...79,547,801
Ensembl chr14:79,503,517...79,545,494
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ASF1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASGR1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of ASNS mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of ASNS mRNA] |
CTD |
PMID:22378314 PMID:29453283 PMID:32407927 PMID:33545341 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ASS1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atad3a |
ATPase family, AAA domain containing 3A |
increases expression |
ISO |
Tunicamycin results in increased expression of ATAD3A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:166,350,302...166,370,492
Ensembl chr 5:166,350,304...166,370,482
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATF3 mRNA |
CTD |
PMID:17127020 PMID:22935518 PMID:29453283 PMID:33545341 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf4 |
activating transcription factor 4 |
increases phosphorylation increases expression multiple interactions |
ISO EXP |
Tunicamycin results in increased phosphorylation of ATF4 protein Tunicamycin results in increased expression of ATF4 mRNA; Tunicamycin results in increased expression of ATF4 protein 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [Tunicamycin results in increased expression of SESN2 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of ATF4 protein] |
CTD |
PMID:14604972 PMID:22001960 PMID:22115781 PMID:22378314 PMID:22959463 PMID:22959925 PMID:24291486 PMID:24312631 PMID:24648495 PMID:24892553 PMID:27358234 PMID:28688763 PMID:28743512 PMID:28844859 PMID:29453283 PMID:29793971 PMID:30592132 PMID:32357311 PMID:32578922 PMID:32740777 More...
|
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATF5 mRNA |
CTD |
PMID:22378314 PMID:28942281 PMID:29453283 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression decreases cleavage increases cleavage |
EXP ISO |
ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in decreased cleavage of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein; Tunicamycin results in increased expression of ATF6 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]; 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in increased cleavage of ATF6 protein Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form] |
CTD |
PMID:18477628 PMID:22001960 PMID:22378314 PMID:22959463 PMID:22959925 PMID:24648495 PMID:25160872 PMID:26551149 PMID:28399139 PMID:29723631 PMID:29894845 PMID:30592132 PMID:32407927 PMID:32740777 More...
|
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atg13 |
autophagy related 13 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATG13 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases response to substance increases expression |
ISO |
[ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of HSPA5 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of PPP1R15A mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of SQSTM1 protein; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of XBP1 mRNA; ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] Tunicamycin results in increased expression of ATG5 mRNA |
CTD |
PMID:29793971 |
|
NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATL2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP2A2 mRNA |
CTD |
PMID:17127020 PMID:29453283 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5G3 mRNA; Tunicamycin results in decreased expression of ATP5MC3 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp5mf |
ATP synthase membrane subunit f |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5MF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP5PD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp6v0a1 |
ATPase H+ transporting V0 subunit a1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V0A1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:85,935,802...85,989,901
Ensembl chr10:85,935,854...85,989,895
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V0A2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:31,949,863...31,979,777
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Atp6v0e1 |
ATPase H+ transporting V0 subunit e1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V0E1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V1D mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:97,656,725...97,672,211
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP6V1G1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Atp6v1g2 |
ATPase H+ transporting V1 subunit G2 |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP6V1G2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr20:3,587,681...3,591,309
Ensembl chr20:3,587,686...3,590,481
|
|
G |
Atp7b |
ATPase copper transporting beta |
increases expression |
ISO |
Tunicamycin results in increased expression of ATP7B mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp8a1 |
ATPase phospholipid transporting 8A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ATP8A1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
|
|
G |
Auh |
AU RNA binding methylglutaconyl-CoA hydratase |
increases expression |
ISO |
Tunicamycin results in increased expression of AUH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:12,329,522...12,424,896
Ensembl chr17:12,329,524...12,424,896
|
|
G |
Aurka |
aurora kinase A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AURKA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of AURKB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B3GALT1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B4GALT1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B4galt5 |
beta-1,4-galactosyltransferase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of B4GALT5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
|
|
G |
B9d1 |
B9 domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of B9D1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
Tunicamycin results in increased expression of BAD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases activity |
ISO |
Tunicamycin results in increased activity of BAK1 protein |
CTD |
PMID:17553788 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BAMBI mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Banf1 |
BAF nuclear assembly factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BANF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BASP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases activity |
ISO |
Tunicamycin results in increased activity of BAX protein |
CTD |
PMID:17553788 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of BBC3 mRNA |
CTD |
PMID:22378314 PMID:33545341 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BCAT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bckdha |
branched chain keto acid dehydrogenase E1 subunit alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of BCKDHA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
|
|
G |
Bckdhb |
branched chain keto acid dehydrogenase E1 subunit beta |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCKDHB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCKDK mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Bcl11a |
BCL11 transcription factor A |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL11A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of BCL2 mRNA Tunicamycin results in increased expression of BCL2 mRNA |
CTD |
PMID:17127020 PMID:33545341 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL2L2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
Tunicamycin results in increased expression of BCL6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bcs1l |
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone |
increases expression |
ISO |
Tunicamycin results in increased expression of BCS1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
|
|
G |
Begain |
brain-enriched guanylate kinase-associated |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BEGAIN mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
|
|
G |
Bend6 |
BEN domain containing 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEND6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:36,081,484...36,135,228
|
|
G |
Best1 |
bestrophin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEST1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063
|
|
G |
Bet1 |
Bet1 golgi vesicular membrane trafficking protein |
increases expression |
ISO |
Tunicamycin results in increased expression of BET1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:32,116,232...32,126,592
Ensembl chr 4:32,116,235...32,126,617
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
increases expression |
ISO |
Tunicamycin results in increased expression of BET1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:195,930,165...195,935,072
Ensembl chr 1:195,931,411...195,935,040
|
|
G |
Bex1 |
brain expressed X-linked 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BEX1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
|
|
G |
Bex2 |
brain expressed X-linked 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BEX2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr X:99,219,015...99,220,411
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BID mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BIRC5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BIRC6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Bloc1s1 |
biogenesis of lysosomal organelles complex-1, subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BLOC1S1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,340,934...1,351,558
|
|
G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BLOC1S2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
|
|
G |
Blzf1 |
basic leucine zipper nuclear factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BLZF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
|
|
G |
Bmp1 |
bone morphogenetic protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BMP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BMP2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
increases expression |
ISO |
Tunicamycin results in increased expression of BMP8A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:135,589,839...135,617,785
Ensembl chr 5:135,591,716...135,617,785
|
|
G |
Bnc2 |
basonuclin 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:98,679,071...99,079,742
Ensembl chr 5:98,687,410...99,079,426
|
|
G |
Bnip1 |
BCL2 interacting protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BNIP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNIP3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BNIP3L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bola3 |
bolA family member 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BOLA3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
|
|
G |
Bphl |
biphenyl hydrolase like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BPHL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
Tunicamycin results in increased expression of BRCA1 protein |
CTD |
PMID:16434996 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression |
ISO |
Tunicamycin results in increased expression of BRCA2 protein |
CTD |
PMID:16434996 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of BRD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brinp1 |
BMP/retinoic acid inducible neural specific 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BRINP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
|
|
G |
Brix1 |
biogenesis of ribosomes BRX1 |
increases expression |
ISO |
Tunicamycin results in increased expression of BRIX1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
|
|
G |
Bsg |
basigin (Ok blood group) |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BSG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
increases expression |
ISO |
Tunicamycin results in increased expression of BSN mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BUB1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of BUB1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Bud31 |
BUD31 homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of BUD31 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C17ORF58 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C1qbp |
complement C1q binding protein |
decreases expression |
ISO |
Tunicamycin results in decreased expression of C1QBP mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C2h1orf162 |
similar to human chromosome 1 open reading frame 162 |
increases expression |
ISO |
Tunicamycin results in increased expression of C1ORF162 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:193,410,730...193,420,824
Ensembl chr 2:193,412,971...193,420,030
|
|
G |
C5h1orf122 |
similar to human chromosome 1 open reading frame 122 |
increases expression |
ISO |
Tunicamycin results in increased expression of C1ORF122 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929
|
|
G |
C9h6orf141 |
similar to human chromosome 6 open reading frame 141 |
increases expression |
ISO |
Tunicamycin results in increased expression of C6ORF141 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
increases expression |
ISO |
Tunicamycin results in increased expression of CACNA1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CACNA2D2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CACNB2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CACNG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:92,686,100...92,745,601
Ensembl chr10:92,683,761...92,746,126
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
increases expression |
ISO |
Tunicamycin results in increased expression of CAD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:25,292,133...25,315,176
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CADM1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calcb |
calcitonin-related polypeptide, beta |
increases expression |
ISO |
Tunicamycin results in increased expression of CALCB mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:168,966,465...168,970,125
Ensembl chr 1:168,966,465...168,970,125
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calm2 |
calmodulin 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CALM3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calr |
calreticulin |
increases expression |
EXP ISO |
Tunicamycin results in increased expression of CALR protein Tunicamycin results in increased expression of CALR mRNA Tunicamycin results in increased expression of CALR mRNA; Tunicamycin results in increased expression of CALR protein |
CTD |
PMID:15049342 PMID:22001960 PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calu |
calumenin |
increases expression multiple interactions decreases expression |
ISO EXP |
Tunicamycin results in increased expression of CALU mRNA ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU mRNA]; ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU protein] Tunicamycin results in decreased expression of CALU mRNA; Tunicamycin results in decreased expression of CALU protein |
CTD |
PMID:22378314 PMID:28399139 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CAMK1D mRNA |
CTD |
PMID:17127020 |
|
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
|
|
G |
Camk1g |
calcium/calmodulin-dependent protein kinase IG |
increases expression |
ISO |
Tunicamycin results in increased expression of CAMK1G mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CAMK4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Canx |
calnexin |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of CANX mRNA; Tunicamycin results in increased expression of CANX protein ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of CANX protein] |
CTD |
PMID:22378314 PMID:27588471 PMID:29453283 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Car10 |
carbonic anhydrase 10 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CA10 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CA2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car5b |
carbonic anhydrase 5B |
increases expression |
ISO |
Tunicamycin results in increased expression of CA5B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:30,474,697...30,534,797
Ensembl chr X:30,474,784...30,533,837
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of CARD9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
|
|
G |
Carhsp1 |
calcium regulated heat stable protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CARHSP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CARS1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp12 |
caspase 12 |
increases cleavage multiple interactions increases activity |
ISO EXP |
Tunicamycin results in increased cleavage of CASP12 protein Nicotine inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein] resveratrol inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein] |
CTD |
PMID:17003819 PMID:18477628 PMID:24224909 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp2 |
caspase 2 |
multiple interactions increases activity decreases expression |
ISO |
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP2 protein] Tunicamycin results in decreased expression of CASP2 mRNA |
CTD |
PMID:16388830 PMID:22378314 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases activity increases expression |
ISO EXP |
Bortezomib promotes the reaction [Tunicamycin results in increased activity of CASP3 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; [spautin-1 results in decreased susceptibility to Tunicamycin] which results in decreased expression of CASP3 protein modified form; Luteolin inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; TRP53 protein affects the reaction [HR protein affects the reaction [Tunicamycin results in increased activity of CASP3 protein]] 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein] |
CTD |
PMID:12871656 PMID:14747384 PMID:16357177 PMID:16388830 PMID:17553788 PMID:19028522 PMID:19735704 PMID:20886113 PMID:24680926 PMID:28399139 PMID:29793971 PMID:31330229 PMID:32407927 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
decreases expression increases cleavage |
ISO |
Tunicamycin results in decreased expression of CASP4 mRNA Tunicamycin results in increased cleavage of CASP4 protein |
CTD |
PMID:17127020 PMID:26551149 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp6 |
caspase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CASP6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases activity increases expression |
ISO |
Tunicamycin results in increased activity of CASP7 protein Tunicamycin results in increased expression of CASP7 protein modified form |
CTD |
PMID:19139269 PMID:31330229 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases cleavage increases expression |
ISO |
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] Tunicamycin results in increased cleavage of CASP9 protein Tunicamycin results in increased expression of CASP9 mRNA Tunicamycin results in increased expression of CASP9 protein modified form |
CTD |
PMID:14747384 PMID:16388830 PMID:17553788 PMID:22378314 PMID:31330229 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cbln2 |
cerebellin 2 precursor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CBLN2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:79,940,412...79,948,766
Ensembl chr18:79,942,590...79,947,855
|
|
G |
Cbs |
cystathionine beta synthase |
increases expression |
ISO |
Tunicamycin results in increased expression of CBS mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cbx4 |
chromobox 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CBX4 mRNA |
CTD |
PMID:22378314 PMID:33545341 |
|
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
|
|
G |
Cbx6 |
chromobox 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CBX6 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 7:111,372,979...111,383,109
Ensembl chr 7:111,372,980...111,383,091
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCAR1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCDC113 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc167 |
coiled-coil domain containing 167 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCDC167 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
|
|
G |
Ccdc171 |
coiled-coil domain containing 171 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCDC171 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
|
|
G |
Ccdc24 |
coiled-coil domain containing 24 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of CCDC24 mRNA Tunicamycin results in decreased expression of CCDC24 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:131,398,766...131,412,395
Ensembl chr 5:131,408,143...131,412,029
|
|
G |
Ccdc28a |
coiled-coil domain containing 28A |
increases expression |
ISO |
Tunicamycin results in increased expression of CCDC28A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] Tunicamycin results in decreased expression of CCL2 mRNA |
CTD |
PMID:18799549 PMID:22378314 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCL20 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCL4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCN3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNA2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNB1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCNB1IP1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCND1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccnt2 |
cyclin T2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCNT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
|
|
G |
Ccnyl1 |
cyclin Y-like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCNYL1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:66,071,721...66,121,742
Ensembl chr 9:66,071,543...66,107,999
|
|
G |
Ccpg1 |
cell cycle progression 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CCPG1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CCT6A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CD24 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd248 |
CD248 molecule |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CD248 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,373,676...202,376,240
Ensembl chr 1:202,373,676...202,376,240
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
Tunicamycin results in increased expression of CD55 mRNA |
CTD |
PMID:17127020 PMID:29453283 PMID:33545341 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
ISO |
Tunicamycin results in increased expression of CD69 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cdc27 |
cell division cycle 27 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDC27 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:89,400,931...89,449,823
Ensembl chr10:89,400,940...89,449,736
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDC45 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc7 |
cell division cycle 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDC7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,804,661...2,824,778
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of CDCA3 mRNA Tunicamycin results in decreased expression of CDCA3 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca7 |
cell division cycle associated 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA7 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
|
|
G |
Cdca7l |
cell division cycle associated 7 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA7L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:138,793,953...138,839,889
Ensembl chr 6:138,794,228...138,839,888
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDCA8 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh10 |
cadherin 10 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH10 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
|
|
G |
Cdh13 |
cadherin 13 |
multiple interactions |
ISO |
Tunicamycin promotes the reaction [HSPA5 protein binds to CDH13 protein] |
CTD |
PMID:23544152 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
|
|
G |
Cdh2 |
cadherin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDH2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh22 |
cadherin 22 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDH22 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK2AP2 mRNA |
CTD |
PMID:17127020 PMID:22378314 PMID:29453283 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK5R1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK5RAP3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:81,894,393...81,903,581
Ensembl chr10:81,894,393...81,903,590
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDK6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDK7 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:31,840,545...31,865,447
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkl3 |
cyclin-dependent kinase-like 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDKL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:36,263,212...36,349,268
Ensembl chr10:36,266,977...36,349,268
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDKN1C mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDO1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cdr2 |
cerebellar degeneration-related protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CDR2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472
|
|
G |
Cdrt4 |
CMT1A duplicated region transcript 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CDRT4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:47,625,448...47,657,493
Ensembl chr10:47,625,470...47,657,493
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of CEBPB mRNA CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:22378314 PMID:28482072 PMID:29453283 PMID:33545341 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of CEBPG mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Celf1 |
CUGBP, Elav-like family member 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CELF1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
|
|
G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CELSR3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPA mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpu |
centromere protein U |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CENPU mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cep44 |
centrosomal protein 44 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP44 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:33,711,548...33,733,226
Ensembl chr16:33,711,559...33,733,225
|
|
G |
Cep55 |
centrosomal protein 55 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP55 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cep68 |
centrosomal protein 68 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CEP68 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517
|
|
G |
Cep95 |
centrosomal protein 95 |
increases expression |
ISO |
Tunicamycin results in increased expression of CEP95 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
Tunicamycin results in increased expression of CFAP300 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfap61 |
cilia and flagella associated protein 61 |
increases expression |
ISO |
Tunicamycin results in increased expression of CFAP61 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
|
|
G |
Cfl1 |
cofilin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CFL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
Tunicamycin results in increased expression of CFLAR mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CGREF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHAC1 mRNA |
CTD |
PMID:29453283 PMID:33545341 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHD1L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd7 |
chromodomain helicase DNA binding protein 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHD7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358
|
|
G |
Chga |
chromogranin A |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of CHGA mRNA Tunicamycin results in increased expression of CHGA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chgb |
chromogranin B |
increases expression |
ISO |
Tunicamycin results in increased expression of CHGB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
|
|
G |
Chpf |
chondroitin polymerizing factor |
increases expression |
ISO |
Tunicamycin results in increased expression of CHPF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHPT1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of CHRNA4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHRNA5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CHRNB4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,418,379...55,436,967
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CHST2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:95,960,067...95,965,803
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression |
ISO |
Tunicamycin results in increased expression of CIDEC mRNA |
CTD |
PMID:22414386 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CILK1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
ISO |
Tunicamycin results in increased expression of CIRBP mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CISD2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CITED1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
|
|
G |
Ckb |
creatine kinase B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CKB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
increases expression |
ISO |
Tunicamycin results in increased expression of CKM mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CKMT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:23,079,920...23,110,518
Ensembl chr 2:23,079,918...23,110,430
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLCC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn6 |
claudin 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLDN6 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
|
|
G |
Clec11a |
C-type lectin domain containing 11A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CLEC11A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:94,800,456...94,809,002
Ensembl chr 1:94,801,496...94,804,633
|
|
G |
Clic5 |
chloride intracellular channel 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of CLIC5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:16,710,980...16,813,427
Ensembl chr 9:16,710,980...16,813,427
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
increases expression |
ISO |
Tunicamycin results in increased expression of CLN3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
|
|
G |
Clstn1 |
calsyntenin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CLSTN1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
|
|
G |
Cmss1 |
cms1 ribosomal small subunit homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of CMSS1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CMTM6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:114,422,681...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cmtm7 |
CKLF-like MARVEL transmembrane domain containing 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CMTM7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:114,448,037...114,474,958
Ensembl chr 8:114,448,042...114,474,621
|
|
G |
Cnn3 |
calponin 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CNN3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cog3 |
component of oligomeric golgi complex 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of COG3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
|
|
G |
Cog6 |
component of oligomeric golgi complex 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of COG6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:137,062,127...137,099,176
Ensembl chr 2:137,061,346...137,099,190
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COL4A1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
increases expression |
ISO |
Tunicamycin results in increased expression of COL4A5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr X:105,118,762...105,322,699
Ensembl chr X:105,118,820...105,322,692
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COL5A1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Colgalt1 |
collagen beta(1-O)galactosyltransferase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COLGALT1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:18,319,796...18,332,106
Ensembl chr16:18,319,795...18,332,106
|
|
G |
Colgalt2 |
collagen beta(1-O)galactosyltransferase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of COLGALT2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr13:64,523,641...64,628,295
Ensembl chr13:64,523,658...64,627,549
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of COMMD5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COMTD1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
|
|
G |
Cop1 |
COP1, E3 ubiquitin ligase |
increases expression |
ISO |
Tunicamycin results in increased expression of COP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:71,467,164...71,561,826
Ensembl chr13:71,429,961...71,538,890
|
|
G |
Copa |
COPI coat complex subunit alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of COPA mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
|
|
G |
Copb1 |
COPI coat complex subunit beta 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPB1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
|
|
G |
Copb2 |
COPI coat complex subunit beta 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:99,161,324...99,183,452
Ensembl chr 8:99,161,350...99,185,197
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Tunicamycin results in increased expression of COPE mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:19,114,871...19,125,527
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of COPG1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Coq10b |
coenzyme Q10B |
increases expression |
ISO |
Tunicamycin results in increased expression of COQ10B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coq3 |
coenzyme Q3 methyltransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COQ3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COQ7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
|
|
G |
Coq8a |
coenzyme Q8A |
increases expression |
ISO |
Tunicamycin results in increased expression of COQ8A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Coro1a |
coronin 1A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CORO1A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
increases expression |
ISO |
Tunicamycin results in increased expression of COX11 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox16 |
cytochrome c oxidase assembly factor COX16 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX16 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 6:101,162,231...101,181,277
Ensembl chr 6:101,019,680...101,181,246
|
|
G |
Cox19 |
cytochrome c oxidase assembly factor COX19 |
increases expression |
ISO |
Tunicamycin results in increased expression of COX19 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
|
|
G |
Cox6b1 |
cytochrome c oxidase subunit 6B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX6B1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX6C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX7B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX7C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of COX8A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:204,402,118...204,404,439
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CPA4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpd |
carboxypeptidase D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CPD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpe |
carboxypeptidase E |
increases expression |
ISO |
Tunicamycin results in increased expression of CPE mRNA |
CTD |
PMID:29453283 |
|
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CPEB3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
Tunicamycin results in increased expression of CPT1C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRABP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRABP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRADD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of CRAT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CREB3L2 mRNA |
CTD |
PMID:17127020 PMID:22378314 PMID:29453283 |
|
NCBI chr 4:65,907,570...66,112,078
Ensembl chr 4:65,907,655...66,023,763
|
|
G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of CREB3L4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:175,690,340...175,696,084
Ensembl chr 2:175,690,335...175,695,932
|
|
G |
Crebrf |
CREB3 regulatory factor |
increases expression |
ISO |
Tunicamycin results in increased expression of CREBRF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRELD1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRELD2 mRNA; Tunicamycin results in increased expression of CRELD2 protein |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRTAC1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CRY1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Crybb2 |
crystallin, beta B2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CRYBB2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:43,569,747...43,579,671
Ensembl chr12:43,569,747...43,579,671
|
|
G |
Cse1l |
chromosome segregation 1 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CSE1L mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
|
|
G |
Csnk1d |
casein kinase 1, delta |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK1D mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Csnk1g1 |
casein kinase 1, gamma 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK1G1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:66,439,760...66,577,247
Ensembl chr 8:66,439,864...66,572,826
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSRNP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CSRP1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CSRP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Ctcf |
CCCTC-binding factor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTCF mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G |
Cth |
cystathionine gamma-lyase |
increases expression |
ISO |
Tunicamycin results in increased expression of CTH mRNA; Tunicamycin results in increased expression of CTH protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNNBL1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Ctnnd2 |
catenin delta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTNND2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:81,168,976...82,016,495
Ensembl chr 2:81,167,117...82,015,764
|
|
G |
Ctps1 |
CTP synthase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CTPS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
Tunicamycin results in increased expression of CTSD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cuedc2 |
CUE domain containing 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CUEDC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
|
|
G |
Cul4a |
cullin 4A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CUL4A mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL2 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of CXCL1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb561d1 |
cytochrome b561 family, member D1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB561D1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:195,834,884...195,837,524
Ensembl chr 2:195,834,740...195,838,243
|
|
G |
Cyb5a |
cytochrome b5 type A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyb5b |
cytochrome b5 type B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cycs |
cytochrome c, somatic |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of CYCS mRNA Tunicamycin results in increased expression of CYCS mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYGB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp2g1 |
cytochrome P450, family 2, subfamily g, polypeptide 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP2G1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:82,145,635...82,156,862
Ensembl chr 1:82,145,073...82,156,828
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP39A1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dach1 |
dachshund family transcription factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DACH1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922
|
|
G |
Dap |
death-associated protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DAP mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DBI mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dbnl |
drebrin-like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DBNL mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DBT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
|
|
G |
Dctpp1 |
dCTP pyrophosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DCTPP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839
|
|
G |
Dcx |
doublecortin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DCX mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDC mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases activity increases expression |
ISO EXP |
Bortezomib inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; SESN2 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; SESN2 protein promotes the reaction [Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of DDIT3]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Tretinoin promotes the reaction [Tunicamycin results in increased expression of DDIT3 mRNA] Tunicamycin results in increased activity of DDIT3 protein 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Guanabenz inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; GW 506033X inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; TGFB1 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein Tunicamycin results in increased expression of DDIT3; Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein |
CTD |
PMID:10542372 PMID:14604972 PMID:16330322 PMID:16357177 PMID:17003819 PMID:17127020 PMID:19028522 PMID:19139269 PMID:19428936 PMID:19735704 PMID:20015086 PMID:20196124 PMID:20477944 PMID:20593179 PMID:20626587 PMID:21321189 PMID:22001960 PMID:22215663 PMID:22378314 PMID:22414386 PMID:22509299 PMID:22935518 PMID:22959463 PMID:22959925 PMID:23684743 PMID:24210820 PMID:24370435 PMID:24648495 PMID:24680926 PMID:24892553 PMID:25160872 PMID:25324550 PMID:27358234 PMID:28399139 PMID:28482072 PMID:28688763 PMID:28698385 PMID:28844859 PMID:28942281 PMID:29027487 PMID:29289645 PMID:29380555 PMID:29453283 PMID:29723631 PMID:29793971 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32574669 PMID:32578922 PMID:32740777 PMID:33127435 PMID:33545341 PMID:34626751 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DDIT4 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of DDOST mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Ddx23 |
DEAD-box helicase 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDX23 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
|
|
G |
Ddx46 |
DEAD-box helicase 46 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DDX46 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:8,944,197...8,988,476
Ensembl chr17:8,944,454...8,988,439
|
|
G |
Ddx49 |
DEAD-box helicase 49 |
increases expression |
ISO |
Tunicamycin results in increased expression of DDX49 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DECR1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dedd2 |
death effector domain containing 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DEDD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
|
|
G |
Depdc1b |
DEP domain containing 1B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DEPDC1B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DEPTOR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Derl2 |
derlin 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DERL2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:55,727,764...55,739,462
Ensembl chr10:55,727,643...55,739,518
|
|
G |
Derl3 |
derlin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DERL3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DGAT1 mRNA |
CTD |
PMID:22414386 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgkk |
diacylglycerol kinase kappa |
increases expression |
ISO |
Tunicamycin results in increased expression of DGKK mRNA |
CTD |
PMID:17127020 |
|
NCBI chr X:15,581,991...15,713,814
Ensembl chr X:15,583,572...15,712,987
|
|
G |
Dglucy |
D-glutamate cyclase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DGLUCY mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:120,055,460...120,130,910
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHCR24 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 5:121,344,637...121,368,853
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHCR7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs13 |
dehydrogenase/reductase 13 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS13 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:62,920,743...62,925,952
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS7 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
increases expression |
ISO |
Tunicamycin results in increased expression of DHRS7B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DHX9 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression |
ISO |
Tunicamycin results in increased expression of DIABLO mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:33,055,784...33,070,400
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DICER1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dis3 |
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DIS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:75,820,040...75,850,450
Ensembl chr15:75,823,436...75,850,642
|
|
G |
Dis3l |
DIS3-like exosome 3'-5' exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DIS3L mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:64,803,925...64,840,306
Ensembl chr 8:64,803,927...64,840,165
|
|
G |
Disp2 |
dispatched RND transporter family member 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DISP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLD mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DLG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLK1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of DLST mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dlx5 |
distal-less homeobox 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DLX5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DMAC2L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dmkn |
dermokine |
increases expression |
ISO |
Tunicamycin results in increased expression of DMKN mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DMRT1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DMTF1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJA3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:10,855,510...10,880,175
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:20196124 |
|
NCBI chr19:24,522,717...24,526,458
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJB11 mRNA; Tunicamycin results in increased expression of DNAJB11 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dnajb2 |
DnaJ heat shock protein family (Hsp40) member B2 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of DNAJB9 mRNA [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of DNAJB9 mRNA] |
CTD |
PMID:22001960 PMID:22378314 PMID:29453283 PMID:29793971 PMID:32407927 PMID:33545341 More...
|
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC10 mRNA; Tunicamycin results in increased expression of DNAJC10 protein |
CTD |
PMID:29453283 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC12 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC15 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc17 |
DnaJ heat shock protein family (Hsp40) member C17 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DNAJC17 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751
|
|
G |
Dnajc25 |
DnaJ heat shock protein family (Hsp40) member C25 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC25 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:73,825,565...73,847,878
Ensembl chr 5:73,825,565...73,845,433
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNAJC3 mRNA; Tunicamycin results in increased expression of DNAJC3 protein |
CTD |
PMID:24312631 PMID:29453283 |
|
NCBI chr15:96,025,729...96,065,114
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
Tunicamycin results in increased expression of DNASE2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr19:23,244,661...23,247,329
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Dnhd1 |
dynein heavy chain domain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DNHD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:159,990,785...160,077,990
Ensembl chr 1:159,990,438...160,074,858
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPAGT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dpf1 |
double PHD fingers 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
|
|
G |
Dph5 |
diphthamide biosynthesis 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPH5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
|
|
G |
Dpp3 |
dipeptidylpeptidase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPP3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPYD mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DPYSL3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr18:35,374,429...35,480,462
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DPYSL4 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Dscam |
DS cell adhesion molecule |
increases expression |
ISO |
Tunicamycin results in increased expression of DSCAM mRNA |
CTD |
PMID:17127020 |
|
NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of DTL mRNA Tunicamycin results in increased expression of DTL mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dus4l |
dihydrouridine synthase 4-like |
increases expression |
ISO |
Tunicamycin results in increased expression of DUS4L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:16,680,489...16,683,276
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of DUSP16 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:167,546,780...167,629,949
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Dusp23 |
dual specificity phosphatase 23 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP23 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:85,098,792...85,099,984
Ensembl chr13:85,097,899...85,100,093
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
Tunicamycin results in increased expression of DUSP26 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUSP5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of DUSP6 mRNA Tunicamycin results in increased expression of DUSP6 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DUT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dxo |
decapping exoribonuclease |
increases expression |
ISO |
Tunicamycin results in increased expression of DXO mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
|
|
G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNC1I1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
|
|
G |
Dync2i2 |
dynein 2 intermediate chain 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNC2I2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,306,039...13,322,121
Ensembl chr 3:13,306,039...13,322,121
|
|
G |
Dynll2 |
dynein light chain LC8-type 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of DYNLL2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
|
|
G |
Dyrk4 |
dual specificity tyrosine phosphorylation regulated kinase 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of DYRK4 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:86,997,331...87,012,901
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of E2F8 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebf1 |
EBF transcription factor 1 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of EBF1 mRNA Tunicamycin results in decreased expression of EBF1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
|
|
G |
Ecd |
ecdysoneless cell cycle regulator |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ECD mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:3,967,209...3,998,713
Ensembl chr15:3,967,382...3,998,706
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ECH1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDEM1 mRNA; Tunicamycin results in increased expression of EDEM1 protein |
CTD |
PMID:19735704 PMID:22378314 PMID:22414386 PMID:24312631 PMID:29453283 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDEM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Edil3 |
EGF like repeats and discoidin domains 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of EDIL3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EEF1A2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EEPD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EFHC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
|
|
G |
Efna1 |
ephrin A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EFNA1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:174,681,676...174,690,306
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Efnb2 |
ephrin B2 |
increases expression decreases expression |
ISO |
Tunicamycin results in increased expression of EFNB2 mRNA Tunicamycin results in decreased expression of EFNB2 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Efs |
embryonal Fyn-associated substrate |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EFS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EGLN1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egr1 |
early growth response 1 |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of EGR1 mRNA Tunicamycin results in increased expression of EGR1 mRNA |
CTD |
PMID:22378314 PMID:29453283 PMID:33545341 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif1 |
eukaryotic translation initiation factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
|
|
G |
Eif1b |
eukaryotic translation initiation factor 1B |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF1B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 8:120,203,561...120,206,176
Ensembl chr 8:120,203,451...120,206,176
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation increases expression |
ISO |
Tunicamycin results in increased phosphorylation of EIF2A protein Tunicamycin results in increased expression of EIF2A mRNA |
CTD |
PMID:20015086 PMID:22378314 PMID:22959463 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions increases response to substance increases phosphorylation |
ISO EXP |
Tunicamycin results in increased expression of EIF2AK3 mRNA Tunicamycin results in increased expression of EIF2AK3 mRNA; Tunicamycin results in increased expression of EIF2AK3 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; Ketoconazole inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to EIF2AK3 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein EIF2AK3 gene mutant form results in increased susceptibility to Tunicamycin Tunicamycin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 protein] |
CTD |
PMID:16330322 PMID:22001960 PMID:22378314 PMID:22509299 PMID:22959925 PMID:24224909 PMID:24648495 PMID:24898257 PMID:26551149 PMID:28399139 PMID:29449374 PMID:29793971 PMID:29894845 PMID:30253173 PMID:30592132 PMID:32740777 More...
|
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
multiple interactions |
ISO |
Tunicamycin inhibits the reaction [[EIF2AK4 gene mutant form affects the susceptibility to Amino Acids deficiency] which results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:29449374 |
|
NCBI chr 3:105,356,261...105,441,630
Ensembl chr 3:105,356,261...105,441,630
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation increases expression |
ISO EXP |
[Tunicamycin results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein; Bortezomib inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; NDRG1 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 protein affects the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Guanabenz promotes the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 mRNA] Tunicamycin results in increased expression of EIF2S1 protein modified form EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:16330322 PMID:16357177 PMID:17553788 PMID:22509299 PMID:24210820 PMID:24224909 PMID:24532803 PMID:24648495 PMID:24892553 PMID:25160872 PMID:28359145 PMID:28844859 PMID:29109149 PMID:29289645 PMID:29449374 PMID:30253173 PMID:30385349 PMID:30592132 PMID:32407927 PMID:32578922 More...
|
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF2S2 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF4E mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4e2 |
eukaryotic translation initiation factor 4E family member 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF4E2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:87,886,078...87,901,058
Ensembl chr 9:87,878,085...87,914,482
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF4EBP1 mRNA; Tunicamycin results in increased expression of EIF4EBP1 protein |
CTD |
PMID:29453283 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF4EBP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:29,379,444...29,400,131
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of EIF5 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:130,589,200...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EIF5B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ELF3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of EMC9 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
|
|
G |
Eml2 |
EMAP like 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of EML2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:78,827,595...78,859,343
Ensembl chr 1:78,828,080...78,859,341
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of EMP3 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENC1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Endog |
endonuclease G |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENDOG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Enkd1 |
enkurin domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ENKD1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:33,592,074...33,596,552
Ensembl chr19:33,592,078...33,596,545
|
|
G |
Eno2 |
enolase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENO2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Enosf1 |
enolase superfamily member 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ENOSF1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 9:113,275,267...113,314,842
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ENPP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPAS1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:7,790,236...7,871,246
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha1 |
Eph receptor A1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EPHA1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
|
|
G |
Epha7 |
Eph receptor A7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPHA7 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
|
|
G |
Ephb2 |
Eph receptor B2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EPHB2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of EPRS1 mRNA; Tunicamycin results in increased expression of EPRS1 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ERBB3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbin |
erbb2 interacting protein |
increases expression |
ISO |
Tunicamycin results in increased expression of ERBIN mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ERCC6L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Tunicamycin results in increased expression of EREG mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
multiple interactions decreases expression |
ISO |
ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased expression of ERGIC3 protein] |
CTD |
PMID:27588471 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERLEC1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression increases phosphorylation |
ISO EXP |
[Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein; Amiloride inhibits the reaction [Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to ERN1 protein]; Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein Tunicamycin results in increased expression of ERN1 mRNA; Tunicamycin results in increased expression of ERN1 protein; Tunicamycin results in increased expression of ERN1 protein modified form Guanabenz inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; KIRA6 inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein] ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein |
CTD |
PMID:17127020 PMID:19139269 PMID:20015086 PMID:21432213 PMID:22001960 PMID:22378314 PMID:24224909 PMID:24892553 PMID:24898257 PMID:25160872 PMID:27588471 PMID:29723631 PMID:29894845 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32740777 More...
|
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of ERO1A mRNA |
CTD |
PMID:12752442 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Ero1b |
endoplasmic reticulum oxidoreductase 1 beta |
increases expression |
ISO |
Tunicamycin results in increased expression of ERO1B mRNA |
CTD |
PMID:12752442 PMID:22378314 PMID:29453283 |
|
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERP29 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERP44 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of ERRFI1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ESPL1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esrrg |
estrogen-related receptor gamma |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ESRRG mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETS2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Etv4 |
ETS variant transcription factor 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETV4 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of ETV5 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Exosc2 |
exosome component 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of EXOSC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
|
|
G |
Exosc5 |
exosome component 5 |
increases expression |
ISO |
Tunicamycin results in increased expression of EXOSC5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Exosc8 |
exosome component 8 |
increases expression |
ISO |
Tunicamycin results in increased expression of EXOSC8 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of F2R mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FABP3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
ISO |
Tunicamycin results in increased expression of FABP4 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of FADS3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
|
|
G |
Faf1 |
Fas associated factor 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of FAF1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of FAIM2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM110A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:140,474,484...140,485,074
Ensembl chr 3:140,474,249...140,485,093
|
|
G |
Fam13b |
family with sequence similarity 13, member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM13B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
|
|
G |
Fam167a |
family with sequence similarity 167, member A |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM167A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
|
|
G |
Fam174b |
family with sequence similarity 174, member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM174B mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:127,515,393...127,618,591
Ensembl chr 1:127,514,041...127,596,128
|
|
G |
Fam20b |
FAM20B, glycosaminoglycan xylosylkinase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM20B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915
|
|
G |
Fam210b |
family with sequence similarity 210, member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM210B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
|
|
G |
Fam222b |
family with sequence similarity 222, member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM222B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM241B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fam24b |
family with sequence similarity 24 member B |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM24B mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 1:186,112,544...186,115,998
Ensembl chr 1:186,112,551...186,115,899
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM3C mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FAM83D mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
increases expression |
ISO |
Tunicamycin results in increased expression of FAM89A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:52,710,003...52,722,591
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Tunicamycin results in increased expression of FAS mRNA |
CTD |
PMID:33770205 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
increases expression decreases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of FASN mRNA Tunicamycin results in decreased expression of FASN mRNA 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA] |
CTD |
PMID:22378314 PMID:22414386 PMID:32407927 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fastkd5 |
FAST kinase domains 5 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FASTKD5 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 3:117,830,227...117,847,737
Ensembl chr 3:117,830,083...117,847,820
|
|
G |
Fbln1 |
fibulin 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBLN1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBP1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbxo16 |
F-box protein 16 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO16 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
|
|
G |
Fbxo17 |
F-box protein 17 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO17 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
|
|
G |
Fbxo32 |
F-box protein 32 |
increases expression |
ISO |
Tunicamycin results in increased expression of FBXO32 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:89,731,626...89,764,761
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fbxw11 |
F-box and WD repeat domain containing 11 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FBXW11 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:17,232,735...17,330,584
Ensembl chr10:17,227,181...17,330,571
|
|
G |
Fcmr |
Fc mu receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FCMR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FDFT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
Tunicamycin results in increased expression of FDXR mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FEN1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FEZ2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
ISO |
FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; Tunicamycin inhibits the reaction [FGF21 protein inhibits the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]] FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:29289645 |
|
NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
increases expression |
ISO |
Tunicamycin results in increased expression of FGF9 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
increases expression |
ISO |
Tunicamycin results in increased expression of FGGY mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases expression |
ISO |
Tunicamycin results in increased expression of FHIT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
ISO |
Tunicamycin results in increased expression of FIBIN mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
ISO |
Tunicamycin results in increased expression of FIBP mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
|
|
G |
Ficd |
FIC domain protein adenylyltransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of FICD mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
|
|
G |
Fjx1 |
four-jointed box kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FJX1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
increases expression |
ISO |
Tunicamycin results in increased expression of FKBP11 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FLT1 mRNA |
CTD |
PMID:24370435 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FMO1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
ISO |
Tunicamycin results in increased expression of FNDC3B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of FOS mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of FOSB mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxa1 |
forkhead box A1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXA1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxd2 |
forkhead box D2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXD2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 5:128,427,986...128,430,869
Ensembl chr 5:128,429,020...128,430,504
|
|
G |
Foxj2 |
forkhead box J2 |
increases expression |
ISO |
Tunicamycin results in increased expression of FOXJ2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:156,047,043...156,073,540
Ensembl chr 4:156,046,969...156,073,518
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXM1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:161,639,561...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxn4 |
forkhead box N4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FOXN4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
|
|
G |
Frmd4a |
FERM domain containing 4A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FRMD4A mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
|
|
G |
Frzb |
frizzled-related protein |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FRZB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FSCN1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of FTH1 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FUCA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
|
|
G |
Fv1 |
Friend virus susceptibility 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of C19ORF48 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:94,730,839...94,736,791
Ensembl chr 1:94,730,606...94,737,594
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FXYD6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of FZD7 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G3bp1 |
G3BP stress granule assembly factor 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of G3BP1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of G6PC mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:22378314 PMID:33545341 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Tunicamycin results in increased expression of GADD45A mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression increases expression |
ISO |
Tunicamycin results in decreased expression of GADD45B mRNA Tunicamycin results in increased expression of GADD45B mRNA |
CTD |
PMID:17127020 PMID:29453283 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of GADD45G mRNA |
CTD |
PMID:29453283 PMID:33545341 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gadd45gip1 |
GADD45G interacting protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GADD45GIP1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr19:23,320,662...23,323,211
Ensembl chr19:23,320,159...23,323,236
|
|
G |
Gal |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GAL mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galc |
galactosylceramidase |
increases expression |
ISO |
Tunicamycin results in increased expression of GALC mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
|
|
G |
Galk2 |
galactokinase 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GALK2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GALNT18 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 1:165,593,180...165,904,268
Ensembl chr 1:165,593,187...165,904,268
|
|
G |
Galr2 |
galanin receptor 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GALR2 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:101,513,689...101,517,176
Ensembl chr10:101,514,471...101,517,176
|
|
G |
Ganab |
glucosidase II alpha subunit |
increases expression |
ISO |
Tunicamycin results in increased expression of GANAB mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 1:205,793,810...205,813,701
Ensembl chr 1:205,793,895...205,813,695
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GAP43 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GARS1 mRNA; Tunicamycin results in increased expression of GARS1 protein |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gas2 |
growth arrest-specific 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GAS2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GAS2L3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gata2 |
GATA binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATD3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gatm |
glycine amidinotransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GATM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G |
Gcat |
glycine C-acetyltransferase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GCAT mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gcc1 |
GRIP and coiled-coil domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GCC1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:57,030,817...57,042,682
Ensembl chr 4:57,032,314...57,042,663
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GCDH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
Tunicamycin results in increased expression of GCLC mRNA NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA] |
CTD |
PMID:22959925 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GCLM mRNA |
CTD |
PMID:17127020 PMID:29453283 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Tunicamycin results in increased expression of GDF15 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf6 |
growth differentiation factor 6 |
increases expression |
ISO |
Tunicamycin results in increased expression of GDF6 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567
|
|
G |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GFOD1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GFPT1 mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GGA2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
|
|
G |
Ggact |
gamma-glutamylamine cyclotransferase |
increases expression |
ISO |
Tunicamycin results in increased expression of GGACT mRNA |
CTD |
PMID:29453283 |
|
NCBI chr15:99,969,246...99,998,343
Ensembl chr15:99,968,282...99,993,455
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GGH mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
|
|
G |
Ghitm |
growth hormone inducible transmembrane protein |
increases expression |
ISO |
Tunicamycin results in increased expression of GHITM mRNA |
CTD |
PMID:22378314 |
|
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GINS2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gla |
galactosidase, alpha |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLA mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLCCI1 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLDC mRNA |
CTD |
PMID:22378314 PMID:33770205 |
|
NCBI chr 1:227,883,247...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glrx |
glutaredoxin |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GLRX mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glrx3 |
glutaredoxin 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GLRX3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
|
|
G |
Gls |
glutaminase |
increases expression |
ISO |
Tunicamycin results in increased expression of GLS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GLT8D1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Gmeb1 |
glucocorticoid modulatory element binding protein 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GMEB1 mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 5:144,421,151...144,462,448
Ensembl chr 5:144,420,555...144,462,602
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Tunicamycin results in increased expression of GMPPA mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gmppb |
GDP-mannose pyrophosphorylase B |
increases expression |
ISO |
Tunicamycin results in increased expression of GMPPB mRNA |
CTD |
PMID:22378314 PMID:29453283 |
|
NCBI chr 8:108,737,429...108,767,286
Ensembl chr 8:108,693,060...108,767,286
|
|
G |
Gmps |
guanine monophosphate synthase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GMPS mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
|
|
G |
Gnas |
GNAS complex locus |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNAS mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnb1 |
G protein subunit beta 1 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNB1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Gng12 |
G protein subunit gamma 12 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG12 mRNA |
CTD |
PMID:29453283 |
|
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
|
|
G |
Gng2 |
G protein subunit gamma 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNG4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Gngt1 |
G protein subunit gamma transducin 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GNGT1 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:32,006,267...32,009,252
Ensembl chr 4:32,006,267...32,009,252
|
|
G |
Gngt2 |
G protein subunit gamma transducin 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNGT2 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr10:80,776,003...80,784,235
|
|
G |
Gnl3l |
G protein nucleolar 3 like |
increases expression |
ISO |
Tunicamycin results in increased expression of GNL3L mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
|
|
G |
Gnptg |
N-acetylglucosamine-1-phosphate transferase subunit gamma |
increases expression |
ISO |
Tunicamycin results in increased expression of GNPTG mRNA |
CTD |
PMID:29453283 |
|
NCBI chr10:14,252,186...14,257,128
Ensembl chr10:14,251,136...14,257,096
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GNRHR mRNA |
CTD |
PMID:17127020 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
increases expression |
ISO |
Tunicamycin results in increased expression of GNS mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 7:56,889,139...56,923,170
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Golga2 |
golgin A2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:15,583,862...15,604,279
Ensembl chr 3:15,584,039...15,604,279
|
|
G |
Golga3 |
golgin A3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA3 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509
|
|
G |
Golga4 |
golgin A4 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA4 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 8:118,208,200...118,285,003
|
|
G |
Golga5 |
golgin A5 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLGA5 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 6:121,612,389...121,640,552
Ensembl chr 6:121,612,529...121,640,413
|
|
G |
Golph3 |
golgi phosphoprotein 3 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLPH3 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 2:61,348,030...61,376,051
Ensembl chr 2:61,348,030...61,376,049
|
|
G |
Golph3l |
golgi phosphoprotein 3-like |
increases expression |
ISO |
Tunicamycin results in increased expression of GOLPH3L mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 2:183,151,941...183,183,094
Ensembl chr 2:183,153,301...183,183,083
|
|
G |
Gorab |
golgin, RAB6-interacting |
increases expression |
ISO |
Tunicamycin results in increased expression of GORAB mRNA |
CTD |
PMID:22378314 |
|
NCBI chr13:75,745,678...75,762,307
Ensembl chr13:75,745,680...75,762,298
|
|
G |
Gorasp2 |
golgi reassembly stacking protein 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GORASP2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr 3:55,474,448...55,503,570
Ensembl chr 3:55,474,757...55,503,576
|
|
G |
Gosr2 |
golgi SNAP receptor complex member 2 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOSR2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
ISO |
Tunicamycin results in increased expression of GOT1 mRNA |
CTD |
PMID:22378314 PMID:33545341 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GOT2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpc2 |
glypican 2 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GPC2 mRNA |
CTD |
PMID:22378314 |
|
NCBI chr12:17,277,875...17,284,297
Ensembl chr12:17,277,875...17,284,208
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GPI1 mRNA Tunicamycin results in decreased expression of GPI mRNA |
CTD |
PMID:17127020 PMID:22378314 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpm6b |
glycoprotein m6b |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GPM6B mRNA |
CTD |
PMID:22378314 |
|
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
|
|
G |
Gpr137b |
G protein-coupled receptor 137B |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GPR137B mRNA |
CTD |
PMID:29453283 |
|
NCBI chr17:86,003,630...86,041,841
Ensembl chr17:85,966,921...86,041,835
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
decreases expression |
ISO |
Tunicamycin results in decreased expression of GPR146 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
increases expression |
ISO |
Tunicamycin results in increased expression of GPR183 mRNA |
CTD |
PMID:33770205 |
|
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
|
|
G |
Gpr27 |
G protein-coupled receptor 27 |
increases expression |
ISO |
Tunicamycin results in increased expression of GPR27 mRNA |
CTD |
PMID:17127020 |
|
NCBI chr 4:132,328,364...132,329,497
Ensembl chr 4:132,328,364...132,329,497
|
|
G |
Gpr85 |
G protein-coupled receptor 85 |
increases expression |
ISO |
Tunicamycin results in increased expression of GPR85 mRNA |
CTD |
| |